A significant difference was found in expression for HKrT-1 (p≤0.02) and fumarylacetoacetate (p≤0.03), both of which were upregulated in AML, as compared to the other diagnostic groups in the total bone marrow and CD34+ve fractions. This evidence concerns the gene CD34 and acute myeloid leukemia.